|
|
|
|
|
|
|
||
The Journal of General Physiology, Vol 108, 295-313, Copyright © 1996 by The Rockefeller University Press
ARTICLES |
MM Hoffman, LY Wei and PD Roepe
Program in Molecular Pharmacology and Therapeutics, Raymond and Beverly Sackler Foundation Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Multidrug resistance (MDR) mediated by overexpression of the MDR protein (P-glycoprotein) has been associated with intracellular alkalinization, membrane depolarization, and other cellular alterations. However, virtually all MDR cell lines studied in detail have been created via protocols that involve growth on chemotherapeutic drugs, which can alter cells in many ways. Thus it is not clear which phenotypic alterations are explicitly due to MDR protein overexpression alone. To more precisely define the MDR phenotype mediated by hu MDR 1 protein, we co-transfected hu MDR 1 cDNA and a neomycin resistance marker into LR73 Chinese hamster ovary fibroblasts and selected stable G418 (geneticin) resistant transfectants. Several clones expressing different levels of hu MDR 1 protein were isolated. Unlike previous work with hu MDR 1 transfectants, the clones were not further selected with, or maintained on, chemotherapeutic drugs. These clones were analyzed for chemotherapeutic drug resistance, intracellular pH (pHi), membrane electrical potential (Vm), and stability of MDR 1 protein overexpression. LR73/hu MDR 1 clones exhibit elevated pHi and are depolarized, consistent with previous work with LR73/mu MDR 1 transfectants (Luz, J.G. L.Y. Wei, S. Basu, and P.D. Roepe. 1994. Biochemistry. 33:7239-7249). The extent of these perturbations is related to the level of hu MDR 1 protein that is expressed. Cytotoxicity experiments with untransfected LR73 cells with elevated pHi due to manipulating percent CO2 show that the pHi perturbations in the MDR 1 clones can account for much of the measured drug resistance. Membrane depolarization in the absence of MDR protein expression is also found to confer mild drug resistance, and we find that the pHi and Vm changes can conceivably account for the altered drug accumulation measured for representative clones. These data indicate that the MDR phenotype unequivocally mediated by MDR 1 protein overexpression alone can be fully explained by the perturbations in Vm and pHi that accompany this overexpression. In addition, MDR mediated by MDR protein overexpression alone differs significantly from that observed for MDR cell lines expressing similar levels of MDR protein but also exposed to chemotherapeutic drugs.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Brouillard, D. Tondelier, A. Edelman, and M. Baudouin-Legros Drug Resistance Induced by Ouabain via the Stimulation of MDR1 Gene Expression in Human Carcinomatous Pulmonary Cells Cancer Res., February 1, 2001; 61(4): 1693 - 1698. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Mignini, R. Prasad, and E. Borowski Unusual Susceptibility of a Multidrug-Resistant Yeast Strain to Peptidic Antifungals Antimicrob. Agents Chemother., January 1, 2001; 45(1): 223 - 228. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Chen and S. M. Simon In Situ Biochemical Demonstration That P-Glycoprotein Is a Drug Efflux Pump with Broad Specificity J. Cell Biol., March 6, 2000; 148(5): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Weisburg, P. D. Roepe, S. Dzekunov, and D. A. Scheinberg Intracellular pH and Multidrug Resistance Regulate Complement-mediated Cytotoxicity of Nucleated Human Cells J. Biol. Chem., April 16, 1999; 274(16): 10877 - 10888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Maglova, W. E. Crowe, A. A. Altamirano, and J. M. Russell Human cytomegalovirus infection stimulates Cl-/HCO-3 exchanger activity in human fibroblasts Am J Physiol Cell Physiol, August 1, 1998; 275(2): C515 - C526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Altan, Y. Chen, M. Schindler, and S. M. Simon Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy J. Exp. Med., May 18, 1998; 187(10): 1583 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Luker, T. P. Flagg, Q. Sha, K. E. Luker, C. M. Pica, C. G. Nichols, and D. Piwnica-Worms MDR1 P-glycoprotein Reduces Influx of Substrates without Affecting Membrane Potential J. Biol. Chem., December 21, 2001; 276(52): 49053 - 49060. [Abstract] [Full Text] [PDF]
|
|
|
|
